Follisave

About

Funding history · 1 round · $3.5M total

Offices

Q&A

What is Follisave's primary focus?

Follisave is a development-stage medical device company focused on providing a novel, effective, patient-friendly, and cost-effective treatment for hair loss (alopecia) caused by chemotherapy in breast cancer and other cancers.

When was Follisave founded?

Follisave was founded in 2021.

What is Follisave's primary sector?

Follisave's primary sector is Medical Device.

Where is Follisave headquartered?

Follisave is headquartered in Tel-Aviv, Israel.

What is the status of Follisave's technology?

Follisave's technology is Israeli and is currently in clinical trials.

How much funding has Follisave raised in total?

Follisave has raised a total of $3,500,000.

When did Follisave complete its Seed funding round and who were the lead investors?

Follisave completed a Seed funding round in November 2021, with Guangzhou Sino-Israel Biotech Investment Fund (GIBF) as a lead investor.

What target markets is Follisave focused on?

Follisave's target markets include China.